Transient suppression of high-prevalence Kell blood group antigens and concomitant development of a Kell-related antibody that appears to recognize a high-prevalence Kell antigen not previously defined

1International Society of Blood Transfusion. 006 KEL Alleles. Available from isbtweb.org). Accessed 10 May 2024.Search in Google Scholar

2Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–51. doi:10.1182/blood-2009-03-209262.Open DOISearch in Google Scholar

3Pelc-Kłopotowska M, Płoski R, Szczałuba K, et al. A novel KEL c.1414-1G>T allele in a Polish patient with anti-Ku antibody. Transfusion 2022;62:E43–4. doi:10.1111/trf.17040.Open DOISearch in Google Scholar

4Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005;45:1791–5. doi:10.1111/j.1537-2995.2005.00604.x.Open DOISearch in Google Scholar

5Gustavsen A, Njerve IU, Sitras V, Haugen G, Tølløfsrud PA, Akkök ÇA. A young woman with a transfusion-related pregnancy complication. Tidsskr Nor Laegeforen 2020;140. doi:10.4045/tidsskr.19.0117.Open DOISearch in Google Scholar

6Seyfried H, Górska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KL . Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528–36. doi:10.1111/j.1423-0410.1972.tb03846.x.Open DOISearch in Google Scholar

7Beck ML, Marsh WL, Pierce SR, DiNapoli J, Oyen R, Nichols ME. Auto anti-Kp^b associated with weakened antigenicity in the Kell blood group system: a second example. Transfusion 1979;19:197–202. doi:10.1046/j.1537-2995.1979.19279160294.x.Open DOISearch in Google Scholar

8Alvarez A, Rives S, Montoto S, Sanz C, Pereira A. Relative sensitivity of direct antiglobulin test, antibody’s elution and flow cytometry in the serologic diagnosis of immune hemolytic transfusion reactions. Haematologica 2000;85:186–8.Search in Google Scholar

9Geoff D. Human blood groups. 3rd ed. Oxford, UK: Wiley-Blackwell; 2013.Search in Google Scholar

10Wagner T, Lanzer G, Geissler K. Kell expression on myeloid progenitor cells. Leuk Lymphoma 2002;43:479–85. doi:10.1080/10428190290011949.Open DOISearch in Google Scholar

11Johnson ST. JMH blood group system: a review. Immunohematology 2014;30:18–23. doi:10.21307/immunohematology-2019-094.Open DOISearch in Google Scholar

12Shafiq M, Karim F. Red cell antigen loss in a patient with chronic myeloid leukemia: a case of ABO discrepancy. Transfus Apher Sci 2015;52:103–4. doi:10.1016/j.transci.2014.11.004.Open DOISearch in Google Scholar

13Nambiar RK, Narayanan G, Prakash NP, Vijayalakshmi K. Blood group change in acute myeloid leukemia. Proc (Bayl Univ Med Cent) 2017;30:74–5. doi:10.1080/08998280.2017.11929536.Open DOISearch in Google Scholar

14Judd WJ, Annesley TM. The acquired-B phenomenon. Transfus Med Rev 1996;10):111–7. doi:10.1016/s0887-7963(96)80087-3.Open DOISearch in Google Scholar